Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease
Clinical trial NCT07542496 · RECRUITING
Trial details
- NCT number
- NCT07542496
- Sponsor
- Société Algérienne de Formation et Recherche en Oncologie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-15
- Primary completion
- 2027-01-15
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.